Prior to joining Qurr, Dr. Padliya worked closely with the North American salesforce at AB SCIEX to perform several winning demonstrations of accurate high - resolution mass spectrometers that paved the way for new business opportunities with
major pharmaceutical and biotechnology accounts.
We established formal partnerships with
major pharmaceutical and biotechnology companies to develop compounds or identify targets that enhance interneuron function or restore brain rhythms in models of AD and epilepsy.
Not exact matches
Many
major pharmaceutical companies have stopped researching
and developing new antibiotics altogether, shifting more of that responsibility to smaller, nimbler
biotechnology startups.
PsychoGenics works with
pharmaceutical and biotechnology companies, academic institutions
and not - for - profit research foundations to address such
major neurological disorders as: ALS, Huntington's Disease, anxiety, cognitive impairment, depression, psychosis / schizophrenia
and SMA.